PERSPECTIVE THERAPEUTICS, INC.
Income Statement
| Line Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $4.6M | $4.2M | $4.5M | $5.1M | $5.2M |
| Cost of Revenue | $4.4M | $4.4M | $4.4M | $4.4M | $4.1M |
| Gross Profit | $167.0K | $-196.5K | $150.2K | $703.2K | $1.2M |
| Gross Margin | 3.6% | -4.7% | 3.3% | 13.9% | 22.1% |
| Operating Expenses | |||||
| Research & Development | $615.0K | $668.8K | $627.1K | $780.6K | $981.2K |
| SG&A Expense | $2.4M | $2.5M | $2.3M | $2.4M | $2.4M |
| Operating Income | $-4.3M | $-4.6M | $-4.1M | $-3.6M | $-3.0M |
| Operating Margin | -94.2% | -108.7% | -89.9% | -71.0% | -56.6% |
| Interest Expense | $2.0K | $883 | $7 | — | — |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — |
| Net Income | $-3.7M | $-6.0M | $-3.9M | $-3.5M | $-2.8M |
| Net Margin | -79.9% | -141.2% | -85.2% | -68.8% | -54.3% |
| EPS (Basic) | $-0.04 | $-0.08 | $-0.06 | $-0.06 | $-0.06 |
| EPS (Diluted) | $-0.04 | $-0.08 | $-0.06 | $-0.06 | $-0.06 |
| Shares Outstanding (Basic) | 110.0M | 76.8M | 76.8M | 69.2M | 52.9M |
| Shares Outstanding (Diluted) | 110.0M | 76.8M | 76.8M | 69.2M | 52.9M |
| Dividends Per Share | — | — | — | — | — |